Skip to content
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact
Scopus BioPharma - Underwriters Exercise Over-Allotment Option in Full, Brings Total Follow-On Public Offering Proceeds to $10.35 Million (02.08.21) FINAL
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • Investors
    • Company Information
    • Press Releases
    • SEC Filings
    • Stock Data
    • Research Coverage
  • Contact

© 2024 Scopus BioPharma. All rights reserved | Privacy Policy | Cookies Policy